Cargando…

Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling

BACKGROUND: We previously found that high-dose methylprednisolone increased the incidence of critical illness-related corticosteroid insufficiency (CIRCI) and mortality in rats with traumatic brain injury (TBI), whereas low-dose hydrocortisone but not methylprednisolone exerted protective effects. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bin, Bai, Miao, Xu, Xiaojian, Yang, Mengshi, Niu, Fei, Gao, Fei, Liu, Baiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586672/
https://www.ncbi.nlm.nih.gov/pubmed/33100225
http://dx.doi.org/10.1186/s12974-020-02000-2
_version_ 1783600047028436992
author Zhang, Bin
Bai, Miao
Xu, Xiaojian
Yang, Mengshi
Niu, Fei
Gao, Fei
Liu, Baiyun
author_facet Zhang, Bin
Bai, Miao
Xu, Xiaojian
Yang, Mengshi
Niu, Fei
Gao, Fei
Liu, Baiyun
author_sort Zhang, Bin
collection PubMed
description BACKGROUND: We previously found that high-dose methylprednisolone increased the incidence of critical illness-related corticosteroid insufficiency (CIRCI) and mortality in rats with traumatic brain injury (TBI), whereas low-dose hydrocortisone but not methylprednisolone exerted protective effects. However, the receptor-mediated mechanism remains unclear. This study investigated the receptor-mediated mechanism of the opposite effects of different glucocorticoids on the survival of paraventricular nucleus (PVN) cells and the incidence of CIRCI after TBI. METHODS: Based on controlled cortical impact (CCI) and treatments, male SD rats (n = 300) were randomly divided into the sham, CCI, CCI + GCs (methylprednisolone 1 or 30 mg/kg/day; corticosterone 1 mg/kg/day), CCI + methylprednisolone+RU486 (RU486 50 mg/kg/day), and CCI + corticosterone+spironolactone (spironolactone 50 mg/kg/day) groups. Blood samples were collected 7 days before and after CCI. Brain tissues were collected on postinjury day 7 and processed for histology and western blot analysis. RESULTS: We examined the incidence of CIRCI, mortality, apoptosis in the PVN, the receptor-mediated mechanism, and downstream signaling pathways on postinjury day 7. We found that methylprednisolone and corticosterone exerted opposite effects on the survival of PVN cells and the incidence of CIRCI by activating different receptors. High-dose methylprednisolone increased the nuclear glucocorticoid receptor (GR) level and subsequently increased cell loss in the PVN and the incidence of CIRCI. In contrast, low-dose corticosterone but not methylprednisolone played a protective role by upregulating mineralocorticoid receptor (MR) activation. The possible downstream receptor signaling mechanism involved the differential effects of GR and MR on the activity of the Akt/CREB/BDNF pathway. CONCLUSION: The excessive activation of GR by high-dose methylprednisolone exacerbated apoptosis in the PVN and increased CIRCI. In contrast, refilling of MR by corticosterone protects PVN neurons and reduces the incidence of CIRCI by promoting GR/MR rebalancing after TBI.
format Online
Article
Text
id pubmed-7586672
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75866722020-10-27 Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling Zhang, Bin Bai, Miao Xu, Xiaojian Yang, Mengshi Niu, Fei Gao, Fei Liu, Baiyun J Neuroinflammation Research BACKGROUND: We previously found that high-dose methylprednisolone increased the incidence of critical illness-related corticosteroid insufficiency (CIRCI) and mortality in rats with traumatic brain injury (TBI), whereas low-dose hydrocortisone but not methylprednisolone exerted protective effects. However, the receptor-mediated mechanism remains unclear. This study investigated the receptor-mediated mechanism of the opposite effects of different glucocorticoids on the survival of paraventricular nucleus (PVN) cells and the incidence of CIRCI after TBI. METHODS: Based on controlled cortical impact (CCI) and treatments, male SD rats (n = 300) were randomly divided into the sham, CCI, CCI + GCs (methylprednisolone 1 or 30 mg/kg/day; corticosterone 1 mg/kg/day), CCI + methylprednisolone+RU486 (RU486 50 mg/kg/day), and CCI + corticosterone+spironolactone (spironolactone 50 mg/kg/day) groups. Blood samples were collected 7 days before and after CCI. Brain tissues were collected on postinjury day 7 and processed for histology and western blot analysis. RESULTS: We examined the incidence of CIRCI, mortality, apoptosis in the PVN, the receptor-mediated mechanism, and downstream signaling pathways on postinjury day 7. We found that methylprednisolone and corticosterone exerted opposite effects on the survival of PVN cells and the incidence of CIRCI by activating different receptors. High-dose methylprednisolone increased the nuclear glucocorticoid receptor (GR) level and subsequently increased cell loss in the PVN and the incidence of CIRCI. In contrast, low-dose corticosterone but not methylprednisolone played a protective role by upregulating mineralocorticoid receptor (MR) activation. The possible downstream receptor signaling mechanism involved the differential effects of GR and MR on the activity of the Akt/CREB/BDNF pathway. CONCLUSION: The excessive activation of GR by high-dose methylprednisolone exacerbated apoptosis in the PVN and increased CIRCI. In contrast, refilling of MR by corticosterone protects PVN neurons and reduces the incidence of CIRCI by promoting GR/MR rebalancing after TBI. BioMed Central 2020-10-25 /pmc/articles/PMC7586672/ /pubmed/33100225 http://dx.doi.org/10.1186/s12974-020-02000-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Bin
Bai, Miao
Xu, Xiaojian
Yang, Mengshi
Niu, Fei
Gao, Fei
Liu, Baiyun
Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling
title Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling
title_full Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling
title_fullStr Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling
title_full_unstemmed Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling
title_short Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling
title_sort corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via akt/creb/bdnf signaling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586672/
https://www.ncbi.nlm.nih.gov/pubmed/33100225
http://dx.doi.org/10.1186/s12974-020-02000-2
work_keys_str_mv AT zhangbin corticosteroidreceptorrebalancingalleviatescriticalillnessrelatedcorticosteroidinsufficiencyaftertraumaticbraininjurybypromotingparaventricularnuclearcellsurvivalviaaktcrebbdnfsignaling
AT baimiao corticosteroidreceptorrebalancingalleviatescriticalillnessrelatedcorticosteroidinsufficiencyaftertraumaticbraininjurybypromotingparaventricularnuclearcellsurvivalviaaktcrebbdnfsignaling
AT xuxiaojian corticosteroidreceptorrebalancingalleviatescriticalillnessrelatedcorticosteroidinsufficiencyaftertraumaticbraininjurybypromotingparaventricularnuclearcellsurvivalviaaktcrebbdnfsignaling
AT yangmengshi corticosteroidreceptorrebalancingalleviatescriticalillnessrelatedcorticosteroidinsufficiencyaftertraumaticbraininjurybypromotingparaventricularnuclearcellsurvivalviaaktcrebbdnfsignaling
AT niufei corticosteroidreceptorrebalancingalleviatescriticalillnessrelatedcorticosteroidinsufficiencyaftertraumaticbraininjurybypromotingparaventricularnuclearcellsurvivalviaaktcrebbdnfsignaling
AT gaofei corticosteroidreceptorrebalancingalleviatescriticalillnessrelatedcorticosteroidinsufficiencyaftertraumaticbraininjurybypromotingparaventricularnuclearcellsurvivalviaaktcrebbdnfsignaling
AT liubaiyun corticosteroidreceptorrebalancingalleviatescriticalillnessrelatedcorticosteroidinsufficiencyaftertraumaticbraininjurybypromotingparaventricularnuclearcellsurvivalviaaktcrebbdnfsignaling